Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: A serial multimodal MRI study

19Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

We report a case of a patient with highly active anti-retroviral therapy-resistant human immunodeficiency virus (HIV)-associated progressive multifocal leukoencephalopathy (PML). The patient showed an improvement in imaging findings and clinical symptoms after mefloquine was introduced as an additional treatment. Serial assessment of white matter lesions was conducted by proton magnetic resonance spectroscopy (1HMRS) and diffusion-weighted imaging (DWI). As the clinical symptoms improved, the N-acetylaspartate/creatine ratio increased, the choline/creatine ratio decreased, and the elevated ADC value decreased. These concomitant changes suggested that 1H-MRS and DWI were useful for the assessment of the therapeutic effect on PML. © 2012 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Naito, K., Ueno, H., Sekine, M., Kanemitsu, M., Ohshita, T., Nakamura, T., … Matsumoto, M. (2012). Akinetic mutism caused by HIV-associated progressive multifocal leukoencephalopathy was successfully treated with mefloquine: A serial multimodal MRI study. Internal Medicine, 51(2), 205–209. https://doi.org/10.2169/internalmedicine.51.6253

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free